Table 1.
Sex differences in sociodemographic and clinical characteristics in HC and PD patients.
| PD sample (n = 99) | HC sample (n = 62) | |||||||
|---|---|---|---|---|---|---|---|---|
| PD Male (n = 69) | PD Female (n = 30) | F | p | HC Male (n = 31) | HC Female (n = 31) | F | p | |
| Age (years) | 63.36 (8.16) | 65.48 (6.85) | 1. 546 | 0.217 | 64.38 (7.90) | 62.20 (8.42) | 1.109 | 0.297 |
| Education (years) | 13.14 (4.92) | 10.73 (3.90) | 5.637 | 0.020 | 13.23 (4.22) | 12.42 (4.80) | 0.492 | 0.486 |
| MoCA | 24.53 (3.53) | 24.20 (3.65) | 0.186 | 0.668 | 26.10 (3.00) | 26.87 (2.12) | 1.319 | 0.256 |
| GDS-15 | 2.82 (2.52) | 2.54 (2.66) | 0.241 | 0.625 | 1.31 (1.80) | 0.63 (1.02) | 3.203 | 0.079 |
| Disease duration | 6.01 (4.86) | 7.24 (4.54) | 1.374 | 0.244 | – | – | – | – |
| UPDRS III | 26.52 (10.65) | 24.00 (12.33) | 1.063 | 0.305 | – | – | – | – |
| Hoehn and Yahr | 1.97 (0.45) | 2.06 (0.50) | 0.871 | 0.353 | – | – | – | – |
| LEDD | 622.57 (373.62) | 705.45 (491.58) | 0.844 | 0.360 | – | – | – | – |
Values are shown as mean (standard deviation).
HC healthy controls, PD Parkinson’s disease, MoCA Montreal cognitive assessment, GDS-15 geriatric depression scale, UPDRS III unified PD rating scale, motor subscale, LEDD levodopa equivalent daily dose.